Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/4/2025

HAART Regimens Compatible with Rifampin

  • The American Medical Association recommends dolutegravir 50 mg twice daily (not once daily) plus tenofovir/emtricitabine or lamivudine for patients requiring rifampin therapy 1, 2
  • The American Medical Association recommends efavirenz 600 mg daily plus two NRTIs for patients requiring rifampin therapy 1, 2, 3
  • Dolutegravir must be dosed at 50 mg twice daily (not the standard once-daily dose) when co-administered with rifampin for active tuberculosis treatment 1, 2, 3
  • Combine dolutegravir with tenofovir alafenamide (TAF) or tenofovir disoproxil fumarate (TDF) plus emtricitabine (FTC) or lamivudine (3TC) as the NRTI backbone 1, 2
  • Efavirenz 600 mg once daily can be used without dose adjustment when combined with rifampin 1, 2, 3
  • Pair efavirenz with two NRTIs (tenofovir plus emtricitabine or lamivudine) 1, 2

Important Considerations for Tenofovir Alafenamide

  • TAF has a pharmacokinetic interaction with rifampin that reduces TAF levels, though clinical data are limited 1, 2
  • If using TAF with rifampin, close monitoring of HIV RNA levels is essential 1, 2
  • TDF may be the safer tenofovir option when rifampin is required 1

Alternative Option (Third-Line)

  • Ritonavir-boosted protease inhibitor regimens should only be used if dolutegravir and efavirenz are not options 1, 2, 3
  • Requires substituting rifabutin 150 mg daily for rifampin (not using rifampin itself) 1, 2, 3
  • Combine boosted PI with tenofovir/emtricitabine or lamivudine 1, 2

Regimens That Are Contraindicated with Rifampin

  • The following HAART regimens cannot be used with rifampin due to severe drug-drug interactions: Bictegravir/TAF/FTC, dolutegravir/lamivudine (2-drug regimen), darunavir boosted with ritonavir or cobicistat, doravirine, elvitegravir/cobicistat combinations, long-acting cabotegravir plus rilpivirine, and rilpivirine-containing regimens 1, 2, 3

Special Situations

  • For 3HP regimen (weekly rifapentine plus isoniazid for 12 weeks): dolutegravir 50 mg once daily is adequate 1, 2
  • For 1HP regimen (daily rifapentine plus isoniazid for 1 month): dolutegravir 50 mg twice daily is required 1, 2

Critical Timing Considerations

  • Rifampin's enzyme induction reaches maximum effect within 1 week of starting therapy 4

Common Pitfalls to Avoid

  • Never use standard once-daily dolutegravir dosing with rifampin - this will result in subtherapeutic levels and treatment failure 1, 2
  • Do not assume all integrase inhibitors behave similarly - bictegravir cannot be used with rifampin while dolutegravir (at increased dose) can 1, 2, 3
  • Rifabutin is not interchangeable with rifampin for first-line tuberculosis treatment - rifabutin is only used when protease inhibitors are absolutely necessary 1, 2